title: RTOG 0529: Intensity modulated radiation therapy and anal cancer, a step in the right direction?
authors.forename: Joseph M
authors.initials: JM
authors.lastname: Herman
authors.forename: Charles R
authors.initials: CR
authors.lastname: Thomas
mesh_terms: D001003:Anal Canal; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D001005:Anus Neoplasms / Q000628:therapy*; D059248:Chemoradiotherapy / Q000009:adverse effects / Q000379:methods*; D002945:Cisplatin / Q000008:administration & dosage; D002985:Clinical Protocols; D017322:Clinical Trials, Phase II as Topic; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D016685:Mitomycin / Q000008:administration & dosage / Q000009:adverse effects; D011880:Radiotherapy Planning, Computer-Assisted; D050397:Radiotherapy, Intensity-Modulated / Q000009:adverse effects / Q000379:methods*; D016032:Randomized Controlled Trials as Topic; D016879:Salvage Therapy / Q000379:methods
chemical_list: D000970:Antineoplastic Agents; D016685:Mitomycin; D002945:Cisplatin; D005472:Fluorouracil